The increase in the incidence of diseases such as cancer and cardiovascular has led to a rise in demand for intravenous infusion pump devices. As per the report of the National Institutes of Health (NIH), cancer was found to be the major cause of death globally, approximately 17, 35,350 new cases have been diagnosed in the U.S. Thus, the growing number of chronic diseases is expected to drive the growth of the global ambulatory infusion pumps market in the near future.
Access Full Report @ https://www.databridgemarketresearch.com/fr/reports/global-ambulatory-infusion-pumps-market
Data Bridge Market Research analyses that the ambulatory infusion pumps market is expected to reach USD 1,617.77 million by 2029 from USD 810.51 million in 2021, with a CAGR of 10.4% in the forecast period of 2022 to 2029. The increasing healthcare expenditure is anticipated to upsurge the availability of infusion pumps for better treatment with less human medical errors. The enormous health care expenditure is a favorable factor that is likely to create a significant opportunity for market growth in the forecast period.
Growing geriatric population expected to drive the market's growth rate
With the growing age comes a reciprocal rise in the number of elderly patients admitted to hospitals owing to the increasing prevalence of chronic disease. Age is a severe threat factor for any disease progression since age is a crucial parameter affecting fundamental biological mechanisms. Chronic diseases such as cancer hugely arise in the geriatric population, with approximately 60% of cancers occurring in the geriatric populace older than 65. Cancer disease is a very challenging factor in the senior population because they are already suffering from several health-related issues, indicating the increasing demand for infusion pumps in the geriatric population.
The growing age and rising prevalence of chronic diseases increase the demand for early diagnosis. The demand for care, technologies, and services is rising to cure chronic conditions in old age. Therefore, the rise in the geriatric population is anticipated to propel the global ambulatory infusion pumps market growth.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product Type (Devices, and Accessories and Consumables), Usage (Disposable and Reusable), Route of Administration (Subcutaneous, Intravenous, And Epidural), Application (Emergency Medicine, General Anaesthesia, Oncology, Pain Management, Diabetes, Gastroenterology, Neonatology, Others), End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Home Care Settings and Others), Distribution Channel (Direct Tender and Retail Sales)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
B. Braun Melsungen AG (Germany), Baxter (U.S.), Moog, Inc. (U.S.), WalkMed (Israel), KORU Medical Systems (U.S.), Intra Pump Infusion Systems (U.S.), AVNS (U.S.), ICU Medical, Inc. (U.S.), Eitan Medical (Israel), Fresenius Kabi (Germany), Medtronic (Irealand), Micrel Medical Devices (Greece), Ace-medical (South Korea),
|
|
Data Points Covered in the Report
|
In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis:
The ambulatory infusion pumps market is segmented on the basis of product type, usage, route of administration, application, end user and distribution channel.
- On the basis of product type, the global ambulatory infusion pumps market is segmented into devices, accessories, and consumables. In 2022, the devices segment is expected to dominate the global ambulatory infusion pumps market with 63.12% market share due to the ability to distribute fluids in very small volumes and at accurately automated intervals or programmed rates.
- On the basis of usage, the global ambulatory infusion pumps market is segmented into disposable and reusable.
In 2022, the disposable segment of usage segment is anticipated to dominate the ambulatory infusion pumps market
The disposable segment is expected to dominate the global ambulatory infusion pumps market with 54.28% market share due to their independence from an external power supply, lightweight, small size, simplicity of use, elimination of programming errors, and disposability.
- On the basis of route of administration, the global ambulatory infusion pumps market is segmented into intravenous, subcutaneous, and epidural. In 2022, the intravenous segment is expected to dominate the global ambulatory infusion pumps market with 47.30% market share due to the high prevalence of chronic diseases and growing technological advancements in infusion pump systems
- On the basis of application, the global ambulatory infusion pumps market is segmented into pain management, diabetes, oncology, neonatology, gastroenterology, general anesthesia, emergency medicine, and others. In 2022, the pain management segment is expected to dominate the global ambulatory infusion pumps market with 26.02% market share due to the growing usage of delivery fluids such as medications and nutrients in emergencies and the growing technological advancements in infusion pump systems
- On the basis of end-user, the global ambulatory infusion pumps market is segmented into hospitals, home care settings, ambulatory surgical centers, specialty clinics, and others.
In 2022, the hospital segment of end user segment is anticipated to dominate the ambulatory infusion pumps market
The hospital segment is expected to dominate the global ambulatory infusion pumps market with 52.93% market share because the hospital admitted patients have all the facilities. They can directly contact physicians who can diagnose the disease and take immediate action with experts' advice
- On the basis of distribution channels, the global ambulatory infusion pumps market is segmented into direct tender and retail sales. In 2022, the direct tender segment is expected to dominate the global ambulatory infusion pumps market with 58.89%.market share because they have no requirement for doctors' prescriptions and these pumps can be easily purchased
Major Players
Data Bridge Market Research recognizes the following companies as the major ambulatory infusion pumps market players in ambulatory infusion pumps market B. Braun Melsungen AG (Germany), Baxter (U.S.), Moog, Inc. (U.S.), WalkMed (Israel), KORU Medical Systems (U.S.), Intra Pump Infusion Systems (U.S.), AVNS (U.S.). ICU Medical, Inc. (U.S.),
Market Development
- In March 2022, Fresenius Kabi declared that they have acquired Ivenix, Inc., a medical technology company specializing in advanced technologies infusion system. This aid in accelerating the strategic growth in Medtech and biopharmaceuticals that results in expanding the growth of the infusion therapy market
- In February 2022, ICU Medical, Inc., Plum 360 Infusion System once again received best in KLAS honour as top-performing smart pump EMR-integrated. This Best in KLAS designation is based on feedback from thousands of healthcare suppliers in overall Canada and United States and results from in depth side-by-side comparisons of IV smart pump performance in several categories such as operations, product, culture, loyalty, relationship, and value.
Regional Analysis
Geographically, the countries covered in the ambulatory infusion pumps market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
As per Data Bridge Market Research analysis:
North America is the dominant region in ambulatory infusion pumps market during the forecast period 2022 - 2029
North America dominates the ambulatory infusion pumps market due to the rising Incidence of chronic diseases and growing number of surgical procedures performed. Furthermore, the U.S. is anticipated to dominate the ambulatory infusion pumps market due to increasing adoption of advanced technology in infusion pumps and well-developed and growing R&D which is expected further to enhance the market's growth rate in this region.
Asia-Pacific is estimated to be the fastest growing region in ambulatory infusion pumps market the forecast period 2022 - 2029
Asia-Pacific is expected to grow during the forecast period of 2022-2029 due to increasing geriatric population and rising prevalence of chronic diseases. Furthermore, China is likely to dominate the ambulatory infusion pumps market due to the presence of huge number of major market players and an established healthcare system for infusion pumps. These are some major factors among other, which is expected to increase the market growth in this region further.
For more detailed information about ambulatory infusion pumps market report, click here – https://www.databridgemarketresearch.com/fr/reports/global-ambulatory-infusion-pumps-market
